Micro-Niche Ideas for the United Kingdom

She lost 40 pounds on Ozempic in six months. Then her doctor changed her dose and her hunger came back in waves — different timing, different intensity, unpredictable. Her meal plan, built for steady appetite suppression, suddenly stopped working. 15 million Americans are now on GLP-1 medications, and every one of them experiences dose-dependent appetite fluctuation that standard nutrition apps completely ignore. Build the adaptive meal app that syncs with GLP-1 cycles: tracks injection timing and dosage, learns appetite patterns across the cycle, dynamically adjusts meal suggestions based on where the user is in their week, and surfaces high-protein meal options timed to when appetite peaks. The GLP-1 market is growing 200% annually. A dedicated nutrition companion at 4.99/month captures a desperately underserved gap in the fastest-growing health category on earth.